137 search results for: patient burden

ADVENT at ERS-ISIAN 2025
On Demand
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions

In this educational presentation, Profs. Vibeke Backer and Sietze Reitsma cover key aspects of type 2 inflammation and its role in the pathogenesis and management of CRSwNP and practical strategies for optimizing disease control and improving patient outcomes.

The Role of Type 2 Inflammation Across a Range of Pruritic Skin Diseases in Older Adults
Dermatology
The Role of Type 2 Inflammation Across a Range of Pruritic Skin Diseases in Older Adults
expert video

Dr. Butler explores how type 2 inflammation is a common underlying mechanism in several prevalent chronic pruritic skin conditions affecting the elderly, such as CPUO, AD, BP, and PN

View more
Decoding Chronic Itch and More in PN: Implications of Real-World Data for Clinical Practice
Dermatology
Decoding Chronic Itch and More in PN: Implications of Real-World Data for Clinical Practice
expert video

This symposium highlights type 2 inflammation as a key driver of chronic itch and the characteristic skin lesions of prurigo nodularis and evaluates the real-world implications of targeted therapies on clinical practice.

View more
ADVENT On Air | More Than Just Difficulty Swallowing: EoE <b>Burden</b> and Diagnosis
Gastroenterology
ADVENT On Air | More Than Just Difficulty Swallowing: EoE Burden and Diagnosis
Podcast

Hear Dr. Wechsler and Prof. Bredenoord discuss the multifaceted burden of EoE and how to overcome challenges in identifying EoE in clinical practice.

View more
Compounded <b>Burden</b> of Co-existing Type 2 Airway Diseases
Pulmonology
Compounded Burden of Co-existing Type 2 Airway Diseases
expert video

In this video soundbite from the EAACI 2025 symposium, Dr. Brian Lipworth discusses that co-existing type 2 inflammatory diseases are common in patients with CRSwNP​ & increasing severity of asthma is associated with higher severity of CRS and prevalence of nasal polyps. Additionally, he explains that patient burden is substantially greater when asthma and CRSwNP are co-existing.

View more
ADVENT at WCI
On Demand
Decoding Chronic Itch and More in PN: Implications of Real-World Data for Clinical Practice

Join Professors Matthias Augustin and Sarina Elmariah for an engaging ADVENT symposium as they explore the pivotal role of type 2 inflammation in prurigo nodularis and chronic itch.

Type 2 Inflammation Mediates Severe Asthma in Pediatric <b>Patient</b>s
Pulmonology
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
expert video

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

View more
EADV 2025
On Demand
The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of Atopic Dermatitis?

Join Professors Jean-David Bouaziz, Amy Paller, and Alan Irvine for a dynamic presentation on the multifaceted burden of atopic dermatitis, the evolving concept of disease modification, and how targeted systemic therapies may help improve long-term patient outcomes.

ADVENT at ERS 2025
Congress
27
September
2025
Congress
ADVENT at ERS 2025

Join leading pulmonologists across asthma and COPD for educational symposia at the ERS congress in Amsterdam, Netherlands.

Identifying BP: How do symptoms of BP and their severity alter <b>patient</b> diagnosis?
Dermatology
Identifying BP: How do symptoms of BP and their severity alter patient diagnosis?
expert video

Dr. Victoria Werth explains how diagnosing BP can pose many difficulties in patients due to the variation of symptoms and symptom severity. Dr. Werth also discusses what burden and challenges BP patients might expect as a result.

View more
ADVENT On Air Podcast: Unmet Needs and Current Treatment Landscape
Dermatology
ADVENT On Air Podcast: Unmet Needs and Current Treatment Landscape
Podcast

In this podcast, Dr. Teri Greiling and Dr. Daniel Butler discuss the enormous burden patients with bullous pemphigoid experience and how our understanding of the disease pathophysiology may help address unmet treatment needs.

View more